These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35025796)

  • 1. A Rare Case of Pituitary Carcinoma With Bone Metastases: 68Ga-DOTATATE PET/CT Findings.
    Filizoglu N; Ozguven S
    Clin Nucl Med; 2022 Mar; 47(3):e298-e299. PubMed ID: 35025796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solitary Contralateral Adrenal Metastasis of Renal Cell Carcinoma: 68Ga-DOTATATE PET/CT Findings.
    Filizoglu N; Ozguven S
    Clin Nucl Med; 2022 Jan; 47(1):e41-e42. PubMed ID: 34132679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation and Comparison of Somatostatin Receptor Type 2 Immunohistochemical Scoring Systems with 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.
    Yu J; Cao F; Zhao X; Xie Q; Lu M; Li J; Yang Z; Sun Y
    Neuroendocrinology; 2022; 112(4):358-369. PubMed ID: 34077939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual Increased Blood Pool Activity on 68Ga-DOTATATE PET/CT in a Patient With Metastatic Neuroendocrine Disease.
    Sharma A; Navaz AJ; Pandey MK; Parent EE
    Clin Nucl Med; 2022 Feb; 47(2):137-139. PubMed ID: 34690295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-Head Comparison of
    Zhu W; Cheng Y; Wang X; Yao S; Bai C; Zhao H; Jia R; Xu J; Huo L
    J Nucl Med; 2020 Jun; 61(6):897-903. PubMed ID: 31676731
    [No Abstract]   [Full Text] [Related]  

  • 6. Somatostatin receptor imaging with [
    Zhao L; Pang Y; Wang Y; Chen J; Zhuang Y; Zhang J; Zhao L; Sun L; Wu H; Chen X; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1360-1373. PubMed ID: 34665275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 177 Lu-DOTATATE PRRT for Multiple Unusual Metastatic Sites in Neuroendocrine Tumor.
    Parghane RV; Basu S
    Clin Nucl Med; 2022 Oct; 47(10):874-875. PubMed ID: 35353741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant Uptake Between Diagnostic 68Ga-HA-DOTATATE PET/CT and Posttherapy 177Lu-HA-DOTATATE SPECT/CT in Patients With Neuroendocrine Tumors.
    Huizing DMV; Aalbersberg EA; van der Hiel B; Stokkel MPM; Versleijen MWJ
    Clin Nucl Med; 2021 Sep; 46(9):e475-e477. PubMed ID: 33782314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
    Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
    J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordance Between Histopathologic Grading and Dual-Tracer PET/CT Findings in Metastatic NETs and Outcome of
    Adnan A; Basu S
    J Nucl Med Technol; 2022 Sep; 50(3):248-255. PubMed ID: 34876476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 68Ga-DOTATATE PET/CT in Primary Pulmonary Lymphoepithelioma-Like Carcinoma.
    Shang Q; Pang Y; Meng T; Hao B; Chen H
    Clin Nucl Med; 2022 Feb; 47(2):187-189. PubMed ID: 34319951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT and 68Ga-DOTATATE PET/CT Findings in a Patient With Primary Renal Well-Differentiated Neuroendocrine Tumor.
    Şahin R; Baykal Koca S; Yücetaş U; Çermik TF; Ergül N
    Clin Nucl Med; 2022 Jul; 47(7):e503-e505. PubMed ID: 35384913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 68Ga-DOTATATE PET/CT in Pituitary Carcinoma.
    Kaya G; Soydas Turan B; Dagdelen S; Berker M; Tuncel M
    Clin Nucl Med; 2021 Dec; 46(12):996-998. PubMed ID: 34269734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
    Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
    J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in diagnosis of metastatic pituitary carcinoma by 68Ga DOTATATE PET/CT.
    Xiao J; Zhu Z; Zhong D; Ma W; Wang R
    Clin Nucl Med; 2015 Feb; 40(2):e129-31. PubMed ID: 24873798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 68Ga-DOTATATE PET/CT compared to standard imaging in metastatic neuroendocrine tumors: a more sensitive test to detect liver metastasis?
    Jackson T; Darwish M; Cho E; Nagatomo K; Osman H; Jeyarajah DR
    Abdom Radiol (NY); 2021 Jul; 46(7):3179-3183. PubMed ID: 33665733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual Variant of Breast Cancer Presenting With Pituitary Symptoms Detected on 68Ga-DOTATATE PET/CT.
    Dev ID; Puranik AD; Rangarajan V; Purandare NC; Agrawal A; Shah S; Sahay A
    Clin Nucl Med; 2021 Nov; 46(11):e556-e558. PubMed ID: 34172604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing Somatostatin Receptor Imaging in Patients With Neuroendocrine Tumors: The Impact of 99mTc-HYNICTOC SPECT/SPECT/CT Versus 68Ga-DOTATATE PET/CT Upon Clinical Management.
    Kunikowska J; Lewington V; Krolicki L
    Clin Nucl Med; 2017 Dec; 42(12):905-911. PubMed ID: 29076910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic role of 68Ga-DOTATATE PET/CT in the detection of neuroendocrine tumours.
    Łapińska G; Bryszewska M; Fijołek-Warszewska A; Kozłowicz-Gudzińska I; Ochman P; Sackiewicz-Słaby A
    Nucl Med Rev Cent East Eur; 2011; 14(1):16-20. PubMed ID: 21751167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.